The Must Read: Not Capable of Grand Deficit Deal

Jan. 18 (Bloomberg) -- Bloomberg's Tom Keene, Scarlet Fu and Sara Eisen recap the op-ed pieces and analyst notes providing insight behind today's headlines. They speak on Bloomberg Television's "Bloomberg Surveillance."

Teva Said Close to Closing $40.5 Billion Allergan Deal
27:55 - The U.S. Federal Trade Commission is close to signing off on Teva Pharmaceutical's deal to buy Allergan Plc's generics unit for $40.5 billion according to people familiar with the matter. Bloomberg's Elliot Gotkine reports on "Bloomberg Markets Middle East." (Source: Bloomberg)
  • Bracing for Yet Another Global Banking Crisis
  • Brexit Brews Trouble for SABMiller-AB InBev Deal
  • Ford CEO: Brexit and Lower Pound Hurt Us